Item 1.01.
|
Entry into a Material Definitive Agreement.
|
As previously disclosed on August 8, 2019, Vitamin Shoppe, Inc. (the Company) entered into an Agreement and Plan of Merger (as
may be amended from time to time, the Merger Agreement), dated as of August 7, 2019, with Franchise Group, Inc. (formerly known as Liberty Tax, Inc.), a Delaware corporation (Parent), and, Valor Acquisition, LLC, a
Delaware limited liability company and a wholly owned subsidiary of Parent (Merger Sub). Capitalized terms used herein but not otherwise defined have the meaning ascribed to such terms in the Merger Agreement.
On November 11, 2019, the Company, Parent and Merger Sub entered into a First Amendment to Agreement and Plan of Merger (the
Amendment), which, among other things, provides that the Company will merge with and into Merger Sub, with Merger Sub continuing as the Surviving Company and a wholly owned subsidiary of Parent.
The foregoing description of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text
of the Amendment, a copy of which is attached hereto as Exhibit 2.1 and is incorporated herein by reference in its entirety.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
The following
exhibits are filed as part of this report:
Additional Information and Where to Find It
In connection with the proposed transaction, the Company has filed with the United States Securities and Exchange Commission (the SEC) a
preliminary proxy statement and other relevant documents. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, and is not a substitute for the proxy
statement or any other document that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, COMPANY STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING
ANY AMENDMENTS OR SUPPLEMENTS THERETO) CAREFULLY AND IN ITS ENTIRETY, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE THEREIN, WHEN THEY BECOME AVAILABLE BECAUSE
THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE PARTIES TO THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain a copy of the proxy statement and other documents filed by the Company with the
SEC free of charge at the SECs website, http://www.sec.gov, and the Companys website, http://investors.vitaminshoppe.com.
Certain
Information Regarding Participants
The Company and its directors and certain executive officers and employees may be deemed to be participants in the
solicitation of proxies from the holders of Company common stock in respect of the proposed transaction. Information about the directors and executive officers of the Company is set forth in the Companys Annual Report on Form 10-K for the year ended December 29, 2018, filed with the SEC on February 26, 2018, and proxy statement
2